Luye Pharma Group Ltd. | Income Statement
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,173
3,202
3,162
3,409
4,399
6,128
Cost of Goods Sold (COGS) incl. D&A
552
633
610
658
1,028
1,385
Gross Income
2,622
2,568
2,551
2,752
3,371
4,743
SG&A Expense
2,138
1,674
1,604
1,816
2,268
3,048
EBIT
514
-
1,021
1,069
1,103
1,695
Unusual Expense
-
41
-
-
-
27
Non Operating Income/Expense
5
27
79
49
55
149
Interest Expense
30
50
19
36
58
202
Pretax Income
482
913
1,107
1,138
1,287
1,745
Income Tax
70
140
165
94
157
198
Equity in Affiliates
-
-
1
1
-
-
Consolidated Net Income
414
773
943
1,045
1,131
1,547
Net Income
392
762
931
1,042
1,132
1,544
Net Income After Extraordinaries
392
762
931
1,042
1,132
1,544
Net Income Available to Common
392
762
931
1,042
1,132
1,544
EPS (Basic)
0.12
0.25
0.28
0.31
0.35
0.48
Basic Shares Outstanding
3,321
2,995
3,321
3,321
3,258
3,208
EPS (Diluted)
0.12
0.25
0.28
0.31
0.35
0.48
Diluted Shares Outstanding
3,321
2,995
3,321
3,321
3,259
3,222
EBITDA
642
1,078
1,157
1,227
1,384
2,063
Other Operating Expense
31
51
74
134
-
-
Non-Operating Interest Income
4
32
27
56
32
76
Minority Interest Expense
22
11
13
3
1
3
Equity in Affiliates (Pretax)
-
-
-
-
1
1
About Luye Pharma Group
View Profile
